The efficacy and safety of Favipiravir in treatment of COVID-19

favipiravir Favipiravir is being investigated for COVID-19 treatment but is listed as a drug with a heightened risk of causing significant harm if used

Driven by the rapid increase in pediatric cases in Thailand where only favipiravir tablets are commercially available, an urgency existed to formulate this drug favipiravir Favipiravir and molnupiravir had a similar efficacy and safety profile Whether either of the two reduced the risk of complications during the